TerminatedPhase 4

Study In Asthma Control

Canada680 participantsStarted 2004-11-08

Plain-language summary

This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * documented clinical history of asthma and receiving regular maintenance therapy. Exclusion Criteria: * Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1. * History of heavy smoking or substance abuse. * Females who are pregnant or lactating. * Required emergency room treatment for their asthma 12 weeks prior to Visit 1. * Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician. * Other medical criteria will be evaluated at the screening visit.

What they're measuring

Percentage of patients achieving well-controlled asthma at the end of the treatment period.

Trial details

NCT IDNCT00273026

SponsorGlaxoSmithKline

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Asthma trials